Table 1.
Baseline characteristics of VACS participants who reported ever drinking alcohol and smoking cigarettes
| HIV +
|
HIV−
|
p -value | |||
|---|---|---|---|---|---|
| N | mean or % | N | mean or % | ||
| Age, mean (SD) | 2878 | 49.8 (8.3) | 2601 | 51.4 (9.0) | <0.0001 |
| Male, % | 2800 | 97.3% | 2457 | 94.5% | <0.0001 |
| Race White, % | 548 | 19.0% | 592 | 22.8% | 0.001 |
| Race Black, % | 1942 | 67.5% | 1659 | 63.8% | - |
| Race other, % | 388 | 13.5% | 350 | 13.5% | - |
| HCV+, % | 1603 | 55.7% | 894 | 34.4% | <0.0001 |
| Died, % | 882 | 30.7% | 476 | 18.3% | <0.0001 |
| AUDIT-C ≥4 | 1100 | 45.5% | 944 | 50.5% | 0.001 |
| Current smoking, % | 1805 | 64.5% | 1248 | 58.6% | <0.0001 |
| PHQ-9 ≥8 | 913 | 32.0% | 777 | 30.2% | 0.14 |
| Substance use, % | 954 | 33.9% | 684 | 26.8% | <0.0001 |
| - Marijuana, % | 531 | 19.1% | 325 | 12.9% | <0.0001 |
| - Cocaine, % | 488 | 17.7% | 351 | 14.0% | 0.0003 |
| - Stimulants, % | 78 | 2.8% | 45 | 1.8% | 0.01 |
| - Heroin, % | NA* | - | NA* | - | - |
| - Opioid, % | 218 | 8.0% | 211 | 8.5% | 0.51 |
| - Benzodiazepines, % | NA* | - | NA | - | - |
*
Baseline data for heroin and prescription opioids are combined. Benzodiazepine use is not available at baseline.